Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...
Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback